| Trial ID: | L1633 |
| Source ID: | NCT06468371
|
| Associated Drug: |
Dopamine Agonist (Ropinirole)
|
| Title: |
Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hemodialysis|Restless Legs Syndrome|ESRD (End Stage Renal Disease)|Diabetes Complications
|
| Interventions: |
DRUG: Dopamine Agonist (Ropinirole)|OTHER: Excercise training
|
| Outcome Measures: |
Primary: Change in the International Restless Legs Syndrome Study Group (IRLSSG) score, The IRLSS score is a validated instrument used to assess the severity of Restless Legs Syndrome (RLS). It comprises ten questions that evaluate the intensity of symptoms, their impact on sleep and daily life, and the frequency of symptom occurrence. Each question is rated on a scale from 0 (no symptoms) to 4 (severe symptoms). The overall score ranges from 0 to 40., From baseline to 3 months of interval. |
|
| Sponsor/Collaborators: |
Sponsor: Lahore General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
84
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-01-02
|
| Completion Date: |
2024-02-01
|
| Results First Posted: |
|
| Last Update Posted: |
2024-06-21
|
| Locations: |
Lahore General Hospital, Lahore, Lahore, Punjab, 54000, Pakistan
|
| URL: |
https://clinicaltrials.gov/show/NCT06468371
|
